Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells

Several classes of immunomodulators are used for treating relapsing-remitting multiple sclerosis (RRMS). Most of these disease-modifying therapies, except teriflunomide, carry the risk of progressive multifocal leukoencephalopathy (PML), a severely debilitating, often fatal virus-induced demyelinati...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Hara, Bethany A., Gee, Gretchen V., Haley, Sheila A., Morris-Love, Jenna, Nyblade, Charlotte, Nieves, Chris, Hanson, Barbara A., Dang, Xin, Turner, Timothy J., Chavin, Jeffrey M., Lublin, Alex, Koralnik, Igor J., Atwood, Walter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468119/
https://www.ncbi.nlm.nih.gov/pubmed/34575975
http://dx.doi.org/10.3390/ijms22189809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468119/
https://www.ncbi.nlm.nih.gov/pubmed/34575975
http://dx.doi.org/10.3390/ijms22189809

Ejemplares similares